SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Diamondcutter who wrote (5663)2/25/1998 10:40:00 PM
From: Tunica Albuginea  Read Replies (1) of 23519
 
Diamond cutter, I have some Viagra questions; I don't know if they 'll be able to answer/if PFE will be there at all:
a)were the 4000 patients asked beforehand:"do you have nocturnal erections?'.
b)If the answer above is yes,then ask:"were these patients excluded from the study?" (they had psychogenic ED; not real ED ).
c)How were patients with psychogenic ED ( ie, not the REAL ED, ) identified.
d)how many of these 4000 patients had psychogenic ED?
e) how was the degree of severity for organic ED established in the Viagra patients ( ie mild , moderate, severe? ).
f) what was the end point for gauging success: erection? sexual intercourse? etc.

( I am sorry to belabor the issue but it is very important: people with psychogenic ED by and large don't need a drug: they need counseling.)

e)what were PFE's entry criteria for ED for their study?
f) when is the soonest and latest that the Vivus plant will approved by MCA and FDA?

This is all I can think off right now; I will post more if I have any.

Good luck.

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News